EAF151 DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT03115333
Cancer - Brain
Principal Investigator: Ding Wang, MD
CANCER, BRAIN, GLIOBLASTOMA, BRAIN CANCER, RECURRENT
Accepting Participants